“The potential of CRISPR gene-editing technology was realized six months ago, when the Food and Drug Administration approved the first therapy that uses the system to treat sickle-cell anemia. Now, scientists are setting their sights on more complex molecular targets.

If researchers can perfect gene editing tools and program site-specific editing, the technology could be adapted to treat even more kinds of diseases, as well as create more resilient plants and livestock.”

From Axios.